Economic Analysis of Screening, Diagnostic, and Treatment Technologies for Cancer: Reflections and a Roadmap for Prospective Authors

JCO Oncol Pract. 2022 Nov;18(11):733-735. doi: 10.1200/OP.22.00497. Epub 2022 Sep 2.

Authors

Scott D Ramsey^{1

2}, Jonanthan W Friedberg³, John V Cox⁴, Jeffrey M Peppercorn⁵

Affiliations

¹ Fred Hutchinson Cancer Research Center, Seattle, WA.
² University of Washington School of Medicine, Seattle, WA.
³ University of Rochester Wilmot Cancer Institute, Rochester, NY.
⁴ University of Texas, Southwestern Medical Center, Dallas, TX.
⁵ Harvard University, Massachussetts General Hospital, Boston, MA.

PMID: 36054866
DOI: 10.1200/OP.22.00497

No abstract available

Publication types

Editorial

MeSH terms

Cost-Benefit Analysis
Early Detection of Cancer*
Humans
Mass Screening
Neoplasms* / diagnosis
Neoplasms* / epidemiology
Neoplasms* / therapy